Skip to content
OpenCapital
Get started

Nutex Health Inc. NUTX Cash & Equivalents

Cash & Equivalents at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$2.97B-1.1%
HCA Healthcare logo
HCA HealthcareHCA
$940M-11.3%
National Healthcare logo
National HealthcareNHC
$85.53M-5.4%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$888.8M+1,598%
Omnicell logo
OmnicellOMCL
$290.97M-29.8%
ARD
Ardent Health PartnersARDT
$609.69M+23.2%

Other financials

Income statement

See full
Revenue$216.5M+2.2%
Gross profit$91.7M-22.5%
Operating income$81.3M+0.7%
Net income$46.8M+121%
EPS (diluted)$6.52+95.8%

Balance sheet

See full
Total debt$348.9M+4.4%
Total equity$346.3M+75.7%
Total assets$957.3M+25.6%

Cash flow

See full
Operating cash flow$75.5M+48.2%
CapEx$1.2M+1,777%
Free cash flow$74.3M+46.0%

Valuation

See full
Market cap$1.02B+60.5%
Enterprise value$1.15B+30.8%
P/E10.5×+2.0×
P/S1.2×+0.1×

Profitability

See full
Gross margin47.5%-1.3pp
Operating margin31.4%-2.2pp
Net margin11%-0.9pp
FCF margin30.6%+19.4pp

Returns & leverage

See full
Return on equity35.5%-21.2pp
Debt / equity1×-0.7×
Current ratio3.1×+0.9×

Where this comes from

Reported directly by Nutex Health Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Nutex Health Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nutex Health Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nutex Health Inc.'s cash & equivalents?
Nutex Health Inc. (NUTX) reported cash & equivalents of $210.64M in Q1 2026.
How has Nutex Health Inc.'s cash & equivalents changed year-over-year?
Nutex Health Inc.'s cash & equivalents increased by 148.6% year-over-year, from $84.73M to $210.64M.
What is the long-term trend for Nutex Health Inc.'s cash & equivalents?
Over 5 years (2020 to 2025), Nutex Health Inc.'s cash & equivalents has grown at a 485.9% compound annual growth rate (CAGR), from $26.93K to $185.87M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.